ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,596,341 | -12.6% | 1,276,216 | +0.4% | 0.29% | -11.7% |
| Q2 2023 | $30,447,252 | +18.4% | 1,271,284 | -7.0% | 0.33% | -6.2% |
| Q1 2023 | $25,710,899 | +48.4% | 1,367,601 | +25.5% | 0.36% | +40.3% |
| Q4 2022 | $17,330,555 | +1270.0% | 1,089,972 | +1310.2% | 0.25% | +1165.0% |
| Q3 2022 | $1,265,000 | +37.9% | 77,292 | +18.9% | 0.02% | +53.8% |
| Q2 2022 | $917,000 | -80.9% | 65,019 | -44.1% | 0.01% | -74.5% |
| Q3 2020 | $4,796,000 | – | 116,258 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |